Antag Therapeutics ApS
38402056ActivePioneering novel GIP receptor antagonist therapies for treating chronic obesity.
Oversigt
- 7
- Medarbejdere
- Ukendt
- Omsætning
- 2017
- Grundlagt
Nøglebeslutningstagere
Jens Juul Holst
Founder and Professor
Philip Just Larsen
Chief Executive Officer
Mette Rosenkilde
Founder and Professor
Beskrivelse
Antag Therapeutics is a clinical-stage biopharmaceutical company based in Copenhagen, Denmark, dedicated to redefining the treatment of obesity and metabolic disorders. The company focuses on pioneering a novel class of therapies through GIP receptor antagonism to address the limitations of current...
Tags
Nøgleord
Teknologistak
Virksomhedsoplysninger
- Branche
- Ukendt
- Juridisk form
- APS
- Momsnummer
- DK38402056
Beslutningstagere
3 kontakter i FunnelfeedrJens Juul Holst
Founder and Professor
Philip Just Larsen
Chief Executive Officer
Mette Rosenkilde
Founder and Professor
Lignende virksomheder
20 lignende virksomheder i FunnelfeedrAlveus Therapeutics ApS
12 medarbejdereClinical-stage biotech developing next-generation therapies for obesity and metabolic diseases.
ZEALAND PHARMA A/S
520 medarbejdereInnovative biotechnology company developing peptide-based medicines for metabolic health.
ASCENDIS PHARMA A/S
629 medarbejdereGlobal biopharmaceutical company developing innovative therapies using proprietary TransCon technology.
Pephexia Therapeutics ApS
5 medarbejdereDeveloping innovative peptide-based therapies for treating cachexia and sarcopenia.
ZEALAND PHARMA A/S
0 medarbejdereDeveloping peptide medicines for metabolic health challenges globally.
Udforsk mere
Spørgsmål om Antag Therapeutics ApS
Vil du se Funnelfeedr i aktion?
Book en gratis demo og opdag, hvordan Funnelfeedr hjælper dig med at finde og konvertere dine ideelle kunder.
Book en demo